Magnetic resonance imaging (MRI) is the most sensitive radiologic modality in visualizing multiple sclerosis (MS) plaques. However, the monotonous appearance of many lesions limits the usefulness of a single MRI in distinguishing active lesions from inactive ones. The proposed longitudinal studies are designed to utilize state-of-the-art volumetric image analysis and image-guided in vivo proton magnetic resonance spectroscopy (MRS) in combination with the paramagnetic contrast agent gadolinium diethylentriaminepentaacetic acid (GdDTPA) for distinguishing different stages of MRI-defined and clinically correlated disease activity. Volumetric image analysis performed on dual echo thin slices (3 mm) with no interslice gap will allow quantitation of total lesion burden as well as volumes of individual plaques independent of small unavoidable errors in repositioning the patients on serial scans. The number and degree of enhancement of plaques will also be quantified using the image analysis. Multivoxel proton MRS will be performed at short-echo times to visualize lipids and other membrane breakdown products from the plaque-containing as well as adjacent-tissue with a volume resolution on the order of 2 cc. MRS data will be quantitatively analyzed to critically assess the role of lipids, N-acetyl aspartate (NAA) and other MR-visible neurochemicals in the characterization of MS plaques. Linked GdDTPA MRI and MRS should allow us to determine the MRS-defined changes in the neurochemicals in relation to acute changes in regional vascular permeability. Computed Relaxation images should allow the detection of plaques even when they are too small to be resolved on MRI or prior to GdDTPA enhancement. Many of the patients will be scanned at intervals of four weeks up to a period of six months. Magnetic resonance results will be correlated with clinical status. These multi-pronged MA studies should allow us to characterize and follow the evolution of MS plaques and improve our understanding of the pathophysiology of MS. A further significance of these studies is that they may enable us to follow objectively and quantitatively the efficacy of drugs in the treatment of MS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS031499-08
Application #
6188213
Study Section
Neurology A Study Section (NEUA)
Program Officer
Kerza-Kwiatecki, a P
Project Start
1993-04-01
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
8
Fiscal Year
2000
Total Cost
$358,765
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Hasan, Khader M; Gupta, Rakesh K; Santos, Rafael M et al. (2005) Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 21:735-43
Bakshi, Rohit; Minagar, Alireza; Jaisani, Zeenat et al. (2005) Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx 2:277-303
Hasan, Khader M; Narayana, Ponnada A (2003) Computation of the fractional anisotropy and mean diffusivity maps without tensor decoding and diagonalization: Theoretical analysis and validation. Magn Reson Med 50:589-98
Sharma, Rakesh (2002) Serial amino-neurochemicals analysis in progressive lesion analysis of multiple sclerosis by magnetic resonance imaging and proton magnetic resonance spectroscopic imaging. Magn Reson Med Sci 1:169-73
He, Renjie; Narayana, Ponnada A (2002) Automatic delineation of Gd enhancements on magnetic resonance images in multiple sclerosis. Med Phys 29:1536-46
He, Renjie; Narayana, Ponnada A (2002) Global optimization of mutual information: application to three-dimensional retrospective registration of magnetic resonance images. Comput Med Imaging Graph 26:277-92
Wolinsky, Jerry S; Narayana, Ponnada A (2002) Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain. Curr Opin Neurol 15:247-51
Sharma, R; Narayana, P A; Wolinsky, J S (2001) Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 7:221-6
Zacharopoulos, N G; Narayana, P A (1998) Selective measurement of white matter and gray matter diffusion trace values in normal human brain. Med Phys 25:2237-41
Narayana, P A; Doyle, T J; Lai, D et al. (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43:56-71

Showing the most recent 10 out of 23 publications